A carregar...
Intravitreal aflibercept for choroidal neovascularization secondary to angioid streaks in a non-responder to intravitreal ranibizumab
PURPOSE: To report the 12-month outcomes of a patient switching from intravitreal ranibizumab to aflibercept for choroidal neovascularization (CNV) associated with angioid streaks (AS). RESULTS: A 42-year-old Caucasian female with CNV associated with AS underwent intensive treatment with ranibizumab...
Na minha lista:
Publicado no: | Int Med Case Rep J |
---|---|
Main Authors: | , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2018
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6149836/ https://ncbi.nlm.nih.gov/pubmed/30271222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IMCRJ.S166473 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|